Cheek Swab News and Research

RSS

Epigenetic alternations associated with common genital malformation in male babies

An alarming increase in the occurrence of the most common genital malformation in male babies, hypospadias, is likely due to environmental factors, such as toxicant exposure, which alter epigenetic programming in a forming penis.

18 Jan 2023

Study shows clinical value of pharmacogenomic testing for patients with treatment-resistant depression

Pharmacogenetic testing was associated with nearly a two-fold (89 per cent) increase in remission rates compared to treatment as usual in a Centre for Addiction and Mental Health- (CAMH-)led clinical study just published in the journal Translational Psychiatry.

29 Mar 2022

Buccal cell epigenetic biomarkers may predict preterm birth

A signature found in the cheek cells of mothers and fathers of preterm infants may help develop a test to determine whether a pregnancy may end too early.

1 Mar 2022

Newly developed risk scores can help identify childhood obesity risk

Newly developed risk scores synthesize genetic information into an easy-to-interpret metric that could help clinicians identify young children most at risk of developing obesity.

10 Jan 2022

Pharmacogenetic tests can benefit four million UK patients annually

Four million UK patients could benefit annually from genetic testing before being prescribed common medicines, according to new research from the University of East Anglia (UEA) in collaboration with Boots UK and Leiden University (Netherlands).

29 Jan 2021

Easier-to-use coronavirus saliva tests start to catch on

As the coronavirus pandemic broke out across the country, health care providers and scientists relied on the standard method for detecting respiratory viruses: sticking a long swab deep into the nose to get a sample. The obstacles to implementing such testing on a mass scale quickly became clear.

6 Oct 2020

Patient genetics associated with wound microbiome composition and healing

In a first-of-its-kind study, researchers have determined that genetics may play a role in how wounds heal.

22 Jun 2020

Do-it-yourself cheek swab tested as next best thing to detect coronavirus

Coronavirus testing is commonly an unpleasant, even painful experience in which a health care provider pushes a torturously long swab up your nostril. President Donald Trump declared that submitting to the process was "a little bit difficult."

2 May 2020

Scientists could soon develop saliva test for measuring cannabis levels in impaired drivers

In the U.S., those who consume alcohol and drive are often subjected to roadside stops, breathalyzer tests and stiff penalties if their blood alcohol content exceeds certain limits.

31 Mar 2020

Researchers take a close look at invisible communities of microbes in the mouth

Most people know that good oral hygiene - brushing, flossing, and regular dental visits - is linked to good health. Colorado State University microbiome researchers offer fresh evidence to support that conventional wisdom, by taking a close look at invisible communities of microbes that live in every mouth.

2 Mar 2020

New molecular "clock" could help monitor life-altering development disorders in children

Scientists have developed a molecular "clock" that could reshape how pediatricians measure and monitor childhood growth and potentially allow for an earlier diagnosis of life-altering development disorders.

15 Oct 2019

Air Force develops genetic test to predict mental performance

A research psychologist at the Air Force Research Laboratory can predict your mental performance from a cheek swab or blood sample.

22 Mar 2019

Access to real-time genotype data influences prescriber behavior after PCI

Today, in a late-breaking featured clinical research session at the American College of Cardiology Scientific Sessions 2018, researchers from Penn Medicine present first-of-its-kind data on the impact of real-time CYP2C19 genotype results when prescribing antiplatelet drugs in the clinic.

13 Mar 2019

New discovery may lead to better treatment options for pancreatic cancer patients

Pancreatic cancer is one of the most difficult cancers to treat and is a leading cause of cancer-related deaths. Now, Sidney Kimmel Cancer Center - Jefferson Health and Lankenau Institute for Medical Research scientists find that a gene involved in the immune system called IDO2 plays a significant role in pancreatic ductal adenocarcinoma, the most common type of pancreatic cancer.

23 Oct 2018

New DNA tool can predict people's height and potentially assess risk for serious illnesses

A new DNA tool created by Michigan State University can accurately predict people's height, and more importantly, could potentially assess their risk for serious illnesses, such as heart disease and cancer.

5 Oct 2018

Bacterial activity in child's mouth may serve as biomarkers for autism spectrum disorder

New research suggests that shifts in the bacteria within a child's mouth could provide objective biomarkers for identifying autism spectrum disorder.

17 Aug 2018

Large study seeking participants to uncover genetic links to autism

Chicagoland families affected by autism can participate in the nation's largest study to uncover genetic links to the condition by attending an on-site registration and data collection event in the western suburbs, Saturday, January 14.

4 Jan 2017

Simple, coordinated approach can improve chances of survival for high-risk AML patients

New research shows that quickly identifying patients with high-risk acute myeloid leukemia (AML), and speeding the process to find them a stem cell donor and performing the transplant earlier, can significantly improve their chances of surviving for at least two years after diagnosis without a relapse.

5 Dec 2016

Automated sample-to-answer system could make EVD diagnosis easier

An automated "sample-to-answer" system could provide Ebola virus disease (EVD) diagnosis more quickly and easily than the current standard test, according to research published this week in PLOS Medicine.

30 Mar 2016

ORIG3N to make debut appearance at 2015 CES Digital Health Summit

ORIG3N Inc., a biotechnology leading a transformation in the understanding and treatment of rare, genetically inherited diseases and a pioneer in regenerative medicine, announces its first appearance at the Digital Health Summit at CES, Jan. 6-9, 2016, in Las Vegas. ORIG3N will highlight AURA, FITCODE, and LifeCapsule, its innovative beauty and health technologies, at the conference.

29 Dec 2015